Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	-20.86	-21.75	-19.56	-18.21	-13.88	-8.27
Depreciation & Amortization	0.35	0.34	0.38	0.39	0.42	0.37
Loss (Gain) From Sale of Assets	-	-	-	-	-	0
Loss (Gain) From Sale of Investments	0	0	0	0.01	-0.02	0
Stock-Based Compensation	1.17	0.83	0.45	0.87	0.63	0.24
Change in Accounts Receivable	0.05	-0.18	-0.05	0	0.03	2.4
Change in Accounts Payable	0.05	0.94	1.36	1.09	0.06	-1.7
Change in Other Net Operating Assets	-0.19	0.41	-0.59	-0.05	-0.08	-0.57
Operating Cash Flow	-19.41	-19.4	-18.01	-15.9	-12.83	-7.54
Capital Expenditures	-0.18	-0.18	-0	-0.01	-0.22	-0.1
Sale of Property, Plant & Equipment	-	-	-	-	-	0
Investing Cash Flow	-0.18	-0.18	-0	-0.01	-0.22	-0.09
Issuance of Common Stock	64.69	73.92	17.88	-	25.75	2.25
Other Financing Activities	-2.93	-5.89	-1.87	-	-3.23	-0.48
Financing Cash Flow	61.77	68.03	16.02	-	22.52	1.77
Foreign Exchange Rate Adjustments	-0.15	-0.01	0.41	0.2	0.5	-0.06
Net Cash Flow	42.03	48.44	-1.59	-15.71	9.97	-5.92
Free Cash Flow	-19.59	-19.58	-18.01	-15.91	-13.05	-7.63
Free Cash Flow Margin	-	-	-24017.33%	-21797.26%	-22123.73%	-7480.39%
Free Cash Flow Per Share	-3.17	-4.82	-13.00	-33.10	-51.66	-127.02
Levered Free Cash Flow	-12.52	-11.68	-10.19	-8.72	-7.28	-4.33
Unlevered Free Cash Flow	-12.52	-11.68	-10.16	-8.7	-7.28	-4.33
Change in Net Working Capital	-0.14	-1.38	-0.93	-1.21	-0.38	-0.33

Source: S&P Capital IQ. Standard template. Financial Sources.